Table of Contents
Table of Contents
Preface
Introduction
Summary of Published Series of Patients with CLM and EHD
Extrahepatic Disease, By Organs
Conclusion
References
Index
Patient with Colorectal Metachronous Liver Metastases Associated with Extrahepatic Disease: Surgical Strategies
$0.00
José Manuel Ramia Ángel, Roberto de la Plaza Llamas and José Edecio Quiñones Sampedro
Guadalajara University Hospital, Guadalajara, Spain
Series: Cancer Etiology, Diagnosis and Treatments
BISAC: MED062000
Colorectal cancer (CRC) is the third most frequent neoplasm in the world, with an approximate incidence of 54 cases per 100,000 inhabitants in men and 34 per 100,000 in women. CRC is the second most frequent cause of death due to cancer in developed countries. Half of these patients develop hepatic metastasis in the course of the disease, 25% of them synchronously. The five-year survival of patients with CRC stage IV not treated surgically is 0-7%. Hepatic resection is considered to be the treatment of choice for colorectal liver metastases (CLM). (Imprint: Nova)
Publish with Nova Science Publishers
We publish over 800 titles annually by leading researchers from around the world. Submit a Book Proposal Now!
